CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia

Melinda A. Biernacki(Fred Hutch Cancer Center), Marie Bleakley(Unknown)

Journal of Clinical Investigation

August 23, 2020

10.1172/jci137723

Cited by 111

Related Papers

Neoantigens in Hematologic Malignancies

|Frontiers in Immunology|2020|42

Minor Histocompatibility Antigen-Specific T Cells

|Frontiers in Pediatrics|2020|32

HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation

|Blood|2024|29

Phase I Study of Adoptive Immunotherapy with HA-1-Specific CD8+ and CD4+ Memory T Cells for Children and Adults with Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Trial in Progress

|Blood|2020|6

Post Hematopoietic Cell Transplantation Maintenance Therapy with Low-Dose Azacitidine in a Pediatric Population with High-Risk Myeloid Neoplasms

|Blood|2023|0